In this Issue:
Bleeding risk following PCI
Appropriateness use criteria recommendations for SIHD
MiStent SES® DESSOLVE I and II Trials: 2-year follow-up
Radial vs femoral PCI in women
Bivalirudin or heparin: the EUROMAX trial
OPTIMIZE: 3 vs 12 months of dual antiplatelet therapy
Clinical efficacy of bioresorbable vascular scaffolds
Simple vs complex stenting of coronary artery bifurcation lesions
Fractional flow reserve vs angiography in non-ST elevation MI
A new definition of clinically relevant MI after coronary revascularisation
Please login below to download this issue (PDF)